BIS targets nucleus accumbens
Evidence from:
primary |
all sources
Evidence (1 sources)
intra-NAc injection of the PKC inhibitor BIS.
confidence: 0.93
Sign in
Sign in
intra-NAc injection of the PKC inhibitor BIS.